Citation Impact
Citing Papers
Acute Phase Proteins with Special Reference to C-Reactive Protein and Related Proteins (Pentaxins) and Serum Amyloid A Protein
1983 Standout
Risk Factors for Venous Thromboembolism
2003 Standout
Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
2011 Standout
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
2011 Standout
Hyperplasia and Carcinomas in Pten-Deficient Mice and Reduced PTEN Protein in Human Bladder Cancer Patients
2006 StandoutNobel
Single Preoperative Bladder Instillation of Povidone-Iodine for the Prevention of Postprostatectomy Bacteriuria and Wound Infection
1991
SERUM C‐REACTIVE PROTEIN LEVELS IN DISEASE*
1982
Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer
1999 Standout
The Acute Metabolic Effects of Tumor Necrosis Factor Administration in Humans
1987
Prognostic factors in metastatic prostate cancer
1993
Epsilon aminocaproic acid reduces transfusion requirements in patients with thrombocytopenic hemorrhage
2006
Preventing Catheter-Related Bacteriuria
1999
Neoadjuvant Chemotherapy with Cisplatin and Methotrexate in Patients with Muscle-Invasive Bladder Tumours
2002
Urothelial Carcinoma Associated with the Use of a Chinese Herb (Aristolochia fangchi)
2000 Standout
A randomized trial of the choice of treatment in prostate cancer: design and baseline characteristics
2001
Natural History of Progression After PSA Elevation Following Radical Prostatectomy
1999 Standout
Device‐Associated Infections: A Macroproblem that Starts with Microadherence
2001 Standout
Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.
1996 Standout
Detection of Circulating Tumor Necrosis Factor after Endotoxin Administration
1988 Standout
Elevated Circulating Levels of Tumor Necrosis Factor in Severe Chronic Heart Failure
1990 Standout
C-reactive protein: a critical update
2003 Standout
Neo‐adjuvant (Pre‐emptive) Cisplatin Therapy in Invasive Transitional Cell Carcinoma of the Bladder
1991
Infection Control — A Problem for Patient Safety
2003 Standout
Impact of StatLock securing device on symptomatic catheter-related urinary tract infection: A prospective, randomized, multicenter clinical trial
2006
Intraarterial cisplatin and concurrent radiation for locally advanced bladder cancer.
1989
CATHETER-ASSOCIATED URINARY TRACT INFECTIONS
1997
Mechanisms of Action and Clinical Uses of Estramustine
1990
T1G3 Bladder Tumours: The Case for Conservative Treatment
2003
Maximal Androgen Blockade: Final Analysis of EORTC Phase III Trial 30853
1998
Association of Fibrinogen, C-reactive Protein, Albumin, or Leukocyte Count With Coronary Heart Disease
1998 Standout
Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters
1991
Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials
2006 Standout
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
2011 Standout
EAU Guidelines on Prostate Cancer
2007 Standout
Bladder cancer
2016 Standout
Kidney Injury Molecule-1 (KIM-1): A novel biomarker for human renal proximal tubule injury
2002 Standout
Chemotherapy-Induced Nausea and Vomiting
2008 Standout
Biofilms and catheter-associated urinary tract infections
2003
Natural forms of vitamin E: metabolism, antioxidant, and anti-inflammatory activities and their role in disease prevention and therapy
2014 Standout
Bacterial Interference for Prevention of Urinary Tract Infection: A Prospective, Randomized, Placebo-Controlled, Double-Blind Pilot Trial
2005
Clinical and economic consequences of nosocomial catheter-related bacteriuria
2000
A review of the biomaterials technologies for infection-resistant surfaces
2013 Standout
Adjuvant Chemotherapy for Invasive Bladder Cancer: A 2013 Updated Systematic Review and Meta-Analysis of Randomized Trials
2013
Adverse effects of methods for minimizing perioperative allogeneic transfusion: A critical review of the literature
1998
Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer
2004 Standout
Nephroprotective action of tocotrienol-rich fraction (TRF) from palm oil against potassium dichromate (K2Cr2O7)-induced acute renal injury in rats
2010
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
2015 Standout
Epidemiology of urinary tract infections: incidence, morbidity, and economic costs
2002 Standout
A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis
1995 Standout
Acute-Phase Proteins and Other Systemic Responses to Inflammation
1999 Standout
Guidelines for the Prevention of Intravascular Catheter-related Infections
2011 Standout
The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina
1994 Standout
Experimental disclosure and its moderators: A meta-analysis.
2006 Standout
Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures.
1995 Standout
HOW IS ANDROGEN-DEPENDENT METASTATIC PROSTATE CANCER BEST TREATED?
1996
Endocrine treatment in prostate cancer
2000
Pilot trial of bacterial interference for preventing urinary tract infection
2001
Systematic review and meta‐analysis of monotherapy compared with combined androgen blockade for patients with advanced prostate carcinoma
2002
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Bladder Irrigation with Chlorhexidine for the Prevention of Urinary Infection After Transurethral Operations: A Prospective Controlled Study
1987
Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms
2002 Standout
METASTATIC BLADDER CANCER
1992
Cardiovascular Complications of Estrogen Therapy for Nondisseminated Prostatic Carcinoma: A Preliminary Report from a Randomized Multicenter Study
1986
Is there evidence that chemotherapy is of benefit to patients with carcinoma of the prostate?
1985
Interleukin-6 and the acute phase response
1990 Standout
Preventing Complications of Central Venous Catheterization
2003 Standout
Noninvasive Renal Diagnostic Studies
1988
Randomized controlled trials in hospital epidemiology
1983
Neoadjuvant Chemotherapy in Invasive Bladder Cancer: Update of a Systematic Review and Meta-Analysis of Individual Patient Data
2005 Standout
Infectious Diseases Society of America Guidelines for the Diagnosis and Treatment of Asymptomatic Bacteriuria in Adults
2005 Standout
Normal and abnormal aspects of proteinuria
1986
Bladder Cancer
2020 Standout
PRE-INOCULATION OF URINARY CATHETERS WITH ESCHERICHIA COLI 83972 INHIBITS CATHETER COLONIZATION BY ENTEROCOCCUS FAECALIS
2002
Decision aids for people facing health treatment or screening decisions
2017 Standout
Predictability of Recurrent and Progressive Disease in Individual Patients with Primary Superficial Bladder Cancer
1993
The Prevention of Secondary Haemorrhage after Prostatectomy: the Value of Antifibrinolytic Therapy
1980
Diagnosis, Prevention, and Treatment of Catheter-Associated Urinary Tract Infection in Adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America
2010 Standout
Single-Therapy Androgen Suppression in Men with Advanced Prostate Cancer
2000
Quality of diagnostic staging in patients with bladder cancer: A process‐outcomes link
2014
Single Preoperative Bladder Instillation of Povidone-Iodine for the Prevention of Postprostatectomy Bacteriuria and Wound Infection
1991
Original Articles: Bladder Cancer: Neoadjuvant Cisplatin Chemotherapy Before Radical Cystectomy in Invasive Transitional Cell Carcinoma of the Bladder: A Prospective Randomized Phase III Study
1995
Proposal for classifying the acute emetogenicity of cancer chemotherapy.
1997 Standout
Radical Cystectomy for Bladder Cancer Today—A Homogeneous Series Without Neoadjuvant Therapy
2003 Standout
Adjuvant Chemotherapy in Invasive Bladder Cancer: A Systematic Review and Meta-Analysis of Individual Patient Data
2005
Plasma protein profiles and prognosis in gastric cancer
1982
Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity
2006 Standout
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
Microbial Biofilms: from Ecology to Molecular Genetics
2000 Standout
Hexyl Aminolevulinate Fluorescence Cystoscopy: A New Diagnostic Tool for Photodiagnosis of Superficial Bladder Cancer—A multicenter study
2003
Skeletal complications of malignancy
1997 Standout
Expressive Disclosure and Health Outcomes in a Prostate Cancer Population
2002
Cisplatin as adjunctive treatment for invasive bladder carcinoma: Tolerance and toxicities
1984
Prognostic significance of serum proteins in invasive bladder cancer
1981
Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
2008 Standout
An Evaluation of Serum Protein Profiles in the Long-Term Surveillance of Prostatic Cancer
1980
The Oral Neurokinin-1 Antagonist Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients Receiving High-Dose Cisplatin—The Aprepitant Protocol 052 Study Group
2003 Standout
THE CURRENT STATUS OF BLADDER PRESERVATION IN THE TREATMENT OF MUSCLE INVASIVE BLADDER CANCER
2000
PRE-INOCULATION OF URINARY CATHETERS WITH ESCHERICHIA COLI 83972 INHIBITS CATHETER COLONIZATION BY ENTEROCOCCUS FAECALIS
2002
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout
Works of B. Richards being referenced
Complications of Antifibrinolysis Therapy after Prostatectomy
1979
Results of Medical Research Council Phase II Study of Low Dose Cisplatin and Methotrexate in the Primary Treatment of Locally Advanced (T3 and T4) Transitional Cell Carcinoma of the Bladder
1991
Adjuvant Chemotherapy with Doxorubicin (Adriamycin) and 5–Fluorouracil in T3, NX, MO Bladder Cancer Treated with Radiotherapy
1983
The quality of life of patients with newly diagnosed M1 prostate cancer: Experience with EORTC clinical trial 30853
1996
Interpretation of Biopsies of “Normal” Urothelium in Patients with Superficial Bladder Cancer
1991
Biochemical Monitoring of Carcinoma of Prostate Treated with an LH‐RH Analogue (Zoladex)
1986
Continuous Irrigation of the Bladder after Prostatectomy: Its Effect on Post‐Prostatyectomy Infection
1977
A Comparison of the Effect of Diethylstilbestrol with Low Dose Estramustine Phosphate in the Treatment of Advanced Prostatic Cancer: Final Analysis of a Phase III Trial of the European Organization for Research on Treatment of Cancer
1986
Vincristine in advanced bladder cancer: a European organization for research on treatment of cancer (EORTC) phase II study.
1983
Serum Protein Profiles in Carcinoma of the Kidney
1982
The excretion of and β-galactosidase by patients with renal disease
1970
The Final Analysis of the EORTCGenito-Urinary T ract CancerCo-Operative Group Phase IIIClinical Trial (Protocol 30805)Comparing Orchidectomy,Orchidectomy plus CyproteroneAcetate and Low Dose Stilboestrolin the Management of MetastaticCarcinoma of the Prostate
1995
Estramustine phosphate in prostate cancer
1984
The excretion of and β-galactosidase following surgery to the kidney
1970
Adjuvant Chemotherapy Following Radical Radiotherapy in T3 Bladder Carcinoma
1979
Cooperative studies of systemic chemotherapy
1983
Acute Phase Reactant Proteins in the Clinical Management of Carcinoma of the Bladder
1979
Low‐dose Doxorubicin in the Management of Advanced Carcinoma of the Prostate
1983